Lianwen Zhang
机构:Mayo Clinic, University of Minnesota Rochester, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID:0000-0002-2817-3072
发表论文 76 篇 · 总被引 1679 次 · h-index 26
代表论文
- Clinical Activity of Single Dose Systemic Oncolytic VSV Virotherapy in Patients with Relapsed Refractory T-Cell Lymphoma (2022 · Blood Advances · 被引 44)
- A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses (2023 · Frontiers in Immunology · 被引 35)
- HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration (2022 · Life Sciences · 被引 18)
- Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine (2022 · Vaccine · 被引 14)
- Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 7)
- Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses (2023 · Molecular Therapy · 被引 6)